BBB National Programs Decision Summaries
BBB National Programs provides summaries of all case decisions from the National Advertising Division (NAD), National Advertising Review Board (NARB), Children’s Advertising Review Unit (CARU), Direct Selling Self-Regulatory Council (DSSRC), and Digital Advertising Accountability Program (DAAP). Subscribe to receive a weekly wrap-up of published case decisions in your inbox.
- All
-
5/26/2016 - In Response to NAD Inquiry, Maker of ‘Anti-Aging’ Gin Says Product has Been Discontinued
Bompas & Parr, producer of “Anti-AGin Gin” for Warner Leisure Hotels, has advised the National Advertising Division that the product – promoted as providing a host of anti-aging benefits – has been discontinued and will not be re-issued. -
5/25/2016 - Native Advertising: NAD Reviews Joyus’ Product Videos at Magazine’s Online Edition, Recommends Modifications
The National Advertising Division has recommended that Joyus, Inc. – which sells certain products in partnership with an online magazine – modify content to better assure that consumers who click through to a Joyus video know they will be clicking on an ad. -
5/19/2016 - Beiersdorf Says it Will Discontinue Six-Hour Claim for ‘Aquaphor’ Diaper Rash Cream Following NAD Inquiry
Beiersdorf, Inc., the maker of “Aquaphor Baby Diaper Rash Cream” said it has launched a new advertising campaign and is permanently discontinuing express claims that the product relieves diaper rash in six hours. The company’s statement came in response to an inquiry by the National Advertising Division. -
5/18/2016 - NAD Recommends Intraceuticals Discontinue Challenged Claims for ‘Atoxelene’ Products
The National Advertising Division has recommended that Intraceuticals LLC discontinue certain express and implied claims for the company’s Atoxelene Skin Care Products and Atoxelene Line Wand, including claims that the products work “instantly.” -
5/18/2016 - NAD Recommends Mega-T Discontinue ‘Burns Fat’ Claim; Company Voluntarily Discontinues Certain Other Claims Challenged by CRN
Mega-T, LLC, the maker of “Mega-T Green Tea Fat Burning Supplements,” has said it will permanently discontinue certain advertising claims challenged by the Council for Responsible Nutrition and comply with the recommendations of the National Advertising Division. -
5/17/2016 - NAD Recommends Clorox Modify Packaging to Clarify Role of Zinc Pyrithione in its ‘Glad Tall Kitchen Drawstring Bags’
The National Advertising Division has recommended that The Clorox Company modify product packaging and a free-standing insert to better assure that consumers understand that Clorox’s zinc pyrithione (ZPT) works to prevent odors on the drawstring of the company’s “Glad Tall Kitchen Drawstring Bags.” -
5/12/2016 - NAD Recommends Genomma Modify Current Broadcast Ad for ‘Silka’ to Avoid Certain Comparisons to Other OTC Athlete’s Foot Products
The National Advertising Division has recommended that Genomma Lab USA, Inc. maker of the athlete’s foot product Silka, modify current advertising claims to eliminate certain comparisons to competing over-the-counter products. -
5/09/2016 - NAD Recommends SharkNinja Discontinue Certain Claims Challenged by Dyson, Including ‘2-to-1’ Preference Claim
The National Advertising Division has recommended that SharkNinja Operating, LLC, discontinue the unsupported preference claim that “Americans now choose Shark 2-to-1 over Dyson.” -
4/27/2016 - KLF International Says it will Discontinue Claims for ‘Venus Factor Weight Loss’ in Response to NAD Inquiry
KLF International, Inc., maker of the Venus Factor Weight Loss System National, has said it will discontinue the advertising claims that were a focus of a National Advertising Division inquiry. -
4/13/2016 - NAD Refers Advertising for ‘Steuart’s Pain Formula’ To FTC, Following Advertiser’s Failure to Provide Substantiation for Pain-Relief Claims
The National Advertising Division has referred advertising claims made by Steuart Laboratories, Inc., for its Steuart’s Pain Formula, to the Federal Trade Commission (FTC) for the second time, following the company’s repeated failures to provide substantiation for challenged advertising claims.